Wird geladen...

Safety and efficacy of azacitidine in myelodysplastic syndromes

PURPOSE: The clinical efficacy, different dosages, treatment schedules, and safety of azacitidine are reviewed. SUMMARY: Azacitidine is the first drug FDA-approved for the treatment of myelodysplastic syndromes that has demonstrated improvements in overall survival and delaying time to progression t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Vigil, Carlos E, Martin-Santos, Taida, Garcia-Manero, Guillermo
Format: Artigo
Sprache:Inglês
Veröffentlicht: Dove Medical Press 2010
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2948932/
https://ncbi.nlm.nih.gov/pubmed/20957213
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!